BioAge Labs (BIOA) filed a registration statement Thursday for the potential sale of up to $250 million of securities from time to time in one or more offerings.
The securities cover common and preferred stocks, debt securities, warrants, subscription rights, and units.
Net proceeds will be used for general corporate purposes.